China Isotope & Radiation Corporation published its monthly return for equity issuers, confirming that for the month ended 30 November 2025, there were no changes in its issued or treasury shares. The total number of H Shares remained at 79,968,800, and domestic shares remained at 239,906,100, resulting in a combined authorized share capital of RMB 319,874,900.
The announcement reaffirmed there were no share repurchases, no treasury share movements, and no convertible or warrant exercises during the period. The submission, dated 1 December 2025, indicates that all regulatory requirements and listing obligations were fulfilled, and no new corporate actions were undertaken.
Comments